Baird analyst Joel Beatty lowered the firm’s price target on Arrowhead to $58 from $60 and keeps an Outperform rating on the shares. The analyst said he maintained his rating but admitted the earnings call did leave us feeling less near-term conviction as management confirmed its HBV partnership is likely to end soon.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ARWR: